Cited by

• Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors.

  Wang TW, Chao HS, Chiu HY, Lu CF, Liao CY, Lee Y, Chen JR, Shiao TH, Chen YM, Wu YT. Wang TW, et al. Transl Oncol. 2024 Jan;39:101826. doi: 10.1016/j.tranon.2023.101826. Epub 2023 Nov 18. Transl Oncol. 2024. PMID: 37984256 Free PMC article.
• AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife.

  Buzea CG, Buga R, Paun MA, Albu M, Iancu DT, Dobrovat B, Agop M, Paun VP, Eva L. Buzea CG, et al. Diagnostics (Basel). 2023 Sep 4;13(17):2853. doi: 10.3390/diagnostics13172853. Diagnostics (Basel). 2023. PMID: 37685391 Free PMC article.
• Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis.

  Li AY, Gaebe K, Zulfiqar A, Lee G, Jerzak KJ, Sahgal A, Habbous S, Erickson AW, Das S. Li AY, et al. JAMA Netw Open. 2023 Feb 1;6(2):e230475. doi: 10.1001/jamanetworkopen.2023.0475. JAMA Netw Open. 2023. PMID: 36821113 Free PMC article.
• Radiomics as an emerging tool in the management of brain metastases.

  Nowakowski A, Lahijanian Z, Panet-Raymond V, Siegel PM, Petrecca K, Maleki F, Dankner M. Nowakowski A, et al. Neurooncol Adv. 2022 Sep 6;4(1):vdac141. doi: 10.1093/noajnl/vdac141. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36284932 Free PMC article. Review.
• Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics.

  Keek SA, Beuque M, Primakov S, Woodruff HC, Chatterjee A, van Timmeren JE, Vallières M, Hendriks LEL, Kraft J, Andratschke N, Braunstein SE, Morin O, Lambin P. Keek SA, et al. Front Oncol. 2022 Jul 13;12:920393. doi: 10.3389/fonc.2022.920393. eCollection 2022. Front Oncol. 2022. PMID: 35912214 Free PMC article.